Loading organizations...
§ Private Profile · Cambridge, MA, USA
Biotechnology company focused on restoring health through autophagy.
PAQ Therapeutics has raised $146.0M across 3 funding rounds.
PAQ Therapeutics has raised $146.0M in total across 3 funding rounds.
PAQ Therapeutics has raised $146.0M in total across 3 funding rounds.
PAQ Therapeutics's investors include Yuexing Su, Olga Danilchanka, Johnson & Johnson Innovation, Lilly Asia Ventures, Sherpa Healthcare Partners, Cheng Xing, Huagai Capital, Matrix Partners China, MRL Ventures Fund, MSA Capital, Nest.Bio Ventures.
PAQ Therapeutics has raised $146.0M across 3 funding rounds. Most recently, it raised $77.0M Series B Extension in January 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 26, 2026 | $77M Series B Plus | — | — | Announced |
| May 7, 2025 | $39M Series B | Yuexing SU, Olga Danilchanka | Johnson & Johnson Innovation, Lilly Asia Ventures, Sherpa Healthcare Partners | Announced |
| Jul 16, 2021 | $30M Series A | Cheng Xing | Huagai Capital, Matrix Partners China, MRL Ventures Fund, MSA Capital, Nest.Bio Ventures | Announced |